TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2011

Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.

Grace A McComsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.